SURI BioTech GmbH

We develop science-based probiotics for infant health

We are a biotechnology company developing probiotic strains with proven mechanisms of action. We specialize in microbiome solutions for health and well-being.

We are dedicated to improve people’s health by targeting the microbiome.

Only registered users have access to funding information.
Please log in or register to continue. Registration is free.

08.04.2024

Multiple startups on the winners' podium (startupticker.ch)

04.07.2023

Venture Leaders Biotech 2023: Captain’s Blog by Navignostics, Mosanna Therapeutics, Limula, and Tandem Therapeutics (venturelab.swiss)

03.07.2023

Swissnex San Francisco Propel Swiss Health Startups into the US Market (startupticker.ch)

19.06.2023

The Venture Leaders Biotech set sail on the Boston roadshow with immersive expert workshops, uniting entrepreneurs and investors in the US market (venturelab.swiss)

07.06.2023

SURI BioTech: The Venture Leader Biotech developing precision probiotics for the first 1,000 days of life (venturelab.swiss)

25.04.2023

Venture Leaders Biotech kick off their Boston roadshow at Swiss Biotech Day (venturelab.swiss)

19.04.2023

Ten biotech startups head to Boston (startupticker.ch)

19.04.2023

Swiss National Startup Team 2023: 10 biotech innovators are headed to Boston (venturelab.swiss)

No milestones

No Jobs

Documents

Our Brochure

Venture Kick

Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.

Venture Kick (50'000) 2021

Website